Botulinum toxin type A combined with cervical spine manual therapy for masseteric hypertrophy in a patient with Alzheimer-type dementia: a case report

Journal of Chiropractic Medicine

Volumn 11, Issue 4, 2012, Pages 280-285

  Villafañe, Jorge H ^a,b   Fernandez de las Peñas, Cesar ^c   Pillastrini, Paolo ^d  

^a Residenza Sanitaria Assistenziale A Maritano ^*  (Italy)

^b Private Practitioner   (Italy)

^c UNIVERSIDAD REY JUAN CARLOS   (Spain)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Alzheimer disease; Botulinum toxin type A; Masseter muscle, cervical spine; Muscle spasticity; Physiotherapy; Stroke

Indexed keywords

EID: 84870018888     PISSN: 15563707     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcm.2012.10.004     Document Type: Article

References (33)

1. Tan E.K., Jankovic J. Treating severe bruxism with botulinum toxin. J Am Dent Assoc 2000, 131(2):211-216.
2. Santamato A., Panza F., Di Venere D., Solfrizzi V., Frisardi V., Ranieri M., et al. Effectiveness of botulinum toxin type A treatment of neck pain related to nocturnal bruxism: a case report. J Chiropr Med 2010, 9(3):132-137.
3. Olivo S.A., Bravo J., Magee D.J., Thie N.M., Major P.W., Flores-Mir C. The association between head and cervical posture and temporomandibular disorders: a systematic review. J Orofac Pain 2006, 20(1):9-23.
4. Eriksson P.O., Zafar H., Nordh E. Concomitant mandibular and head-neck movements during jaw opening-closing in man. J Oral Rehabil 1998, 25(11):859-870.
5. Zafar H., Nordh E., Eriksson P.O. Temporal coordination between mandibular and head-neck movements during jaw opening-closing tasks in man. Arch Oral Biol 2000, 45(8):675-682.
6. Brashear A., Gordon M.F., Elovic E., Kassicieh V.D., Marciniak C., Do M., et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 2002, 347(6):395-400.
7. Kaji R., Osako Y., Suyama K., Maeda T., Uechi Y., Iwasaki M. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial. J Neurol 2010, 257(8):1330-1337.
8. Prager E.M., Birkenmeier R.L., Lang C.E. Exploring expectations for upper-extremity motor treatment in people after stroke: a secondary analysis. Am J Occup Ther 2011, 65(4):437-444.
9. Rodgers H., Shaw L., Price C., van Wijck F., Barnes M., Graham L., et al. Study design and methods of the BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A. Trials 2008, 9:59.
10. Lang R., White P.J., Machalicek W., Rispoli M., Kang S., Aquilar J., et al. Treatment of bruxism in individuals with developmental disabilities: a systematic review. Res Dev Disabil 2009, 30(5):809-818.
11. Chikhani L., Dichamp J. Bruxism, temporo-mandibular dysfunction and botulinum toxin. Ann Readapt Med Phys 2003, 46(6):333-337.
12. de Wijer A., Steenks M.H., Bosman F., Helders P.J., Faber J. Symptoms of the stomatognathic system in temporomandibular and cervical spine disorders. J Oral Rehabil 1996, 23(11):733-741.
13. Kong K.H., Chua K.S., Lee J. Symptomatic upper limb spasticity in patients with chronic stroke attending a rehabilitation clinic: frequency, clinical correlates and predictors. J Rehabil Med 2010, 42(5):453-457.
14. Lundstrom E., Smits A., Terent A., Borg J. Time-course and determinants of spasticity during the first six months following first-ever stroke. J Rehabil Med 2010, 42(4):296-301.
15. Prasad K., Dash D., Kumar A. Validation of the Hindi version of National Institute of Health Stroke Scale. Neurol India 2012, 60(1):40-44.
16. El Maaytah M., Jerjes W., Upile T., Swinson B., Hopper C., Ayliffe P. Bruxism secondary to brain injury treated with botulinum toxin-A: a case report. Head Face Med 2006, 2:41.
17. Platz T., Eickhof C., Nuyens G., Vuadens P. Clinical scales for the assessment of spasticity, associated phenomena, and function: a systematic review of the literature. Disabil Rehabil 2005, 27(1-2):7-18.
18. Cousins E., Ward A.B., Roffe C., Rimington L.D., Pandyan A.D. Quantitative measurement of poststroke spasticity and response to treatment with botulinum toxin: a 2-patient case report. Phys Ther 2009, 89(7):688-697.
19. Jeong B.O., Kang H.J., Bae K.Y., Kim S.W., Kim J.M., Shin I.S., et al. Determinants of quality of life in the acute stage following stroke. Psychiatry Investig 2012, 9(2):127-133.
20. La Touche R., Fernandez-de-las-Penas C., Fernandez-Carnero J., Escalante K., Angulo-Diaz-Parreno S., Paris-Alemany A., et al. The effects of manual therapy and exercise directed at the cervical spine on pain and pressure pain sensitivity in patients with myofascial temporomandibular disorders. J Oral Rehabil 2009, 36(9):644-652.
21. Bhakta B.B., Cozens J.A., Bamford J.M., Chamberlain M.A. Use of botulinum toxin in stroke patients with severe upper limb spasticity. J Neurol Neurosurg Psychiatry 1996, 61(1):30-35.
22. Chiu T.W., Wright A. To compare the effects of different rates of application of a cervical mobilisation technique on sympathetic outflow to the upper limb in normal subjects. Man Ther 1996, 1(4):198-203.
23. Thompson B.A., Blount B.W., Krumholz T.S. Treatment approaches to bruxism. Am Fam Physician 1994, 49(7):1617-1622.
24. Watts M.W., Tan E.K., Jankovic J. Bruxism and cranial-cervical dystonia: is there a relationship?. Cranio 1999, 17(3):196-201.
25. Wooten M.W., Seibenhener M.L., Zhou G., Vandenplas M.L., Tan T.H. Overexpression of atypical PKC in PC12 cells enhances NGF-responsiveness and survival through an NF-kappaB dependent pathway. Cell Death Differ 1999, 6(8):753-764.
26. Ivanhoe C.B., Lai J.M., Francisco G.E. Bruxism after brain injury: successful treatment with botulinum toxin-A. Arch Phys Med Rehabil 1997, 78(11):1272-1273.
27. Van Zandijcke M., Marchau M.M. Treatment of bruxism with botulinum toxin injections. J Neurol Neurosurg Psychiatry 1990, 53(6):530.
28. Schwartz M., Freund B. Treatment of temporomandibular disorders with botulinum toxin. Clin J Pain 2002, 18(6 Suppl):S198-S203.
29. Molina OF, dos Santos J., Nelson S.J., Grossman E. Prevalence of modalities of headaches and bruxism among patients with craniomandibular disorder. Cranio 1997, 15(4):314-325.
30. Ciancaglini R., Gherlone E.F., Radaelli G. The relationship of bruxism with craniofacial pain and symptoms from the masticatory system in the adult population. J Oral Rehabil 2001, 28(9):842-848.
31. Bas B., Ozan B., Muglali M., Celebi N. Treatment of masseteric hypertrophy with botulinum toxin: a report of two cases. Med Oral Patol Oral Cir Bucal 2010, 15(4):e649-e652.
32. Ham J.W. Masseter muscle reduction procedure with radiofrequency coagulation. J Oral Maxillofac Surg 2009, 67(2):457-463.
33. Villafañe J.H., Silva G.B., Chiarotto A., Ragusa O.L. Botulinum toxin type A combined with neurodynamic mobilization for upper limb spasticity after stroke: a case report. J Chiropr Med 2012, 11:186-191.